Neurology Applications in USA
-
Premium
Ultrasound measurement instrumentation solutions for therapeutic sector
The growing adoption of focused ultrasound to treat tissue non-invasively with thermal or mechanical energy requires robust measurements to ensure safety and ...
By Onda Corporation based in Sunnyvale, CALIFORNIA (USA).
-
Medical Devices for Diagnosis and Evaluation
The diagnosis of heart failure typically starts when a patient talks to their caregiver about the signs and symptoms they are experiencing. Their health care provider may ask questions designed to confirm the causes of heart failure that may be in their medical history as ...
By Impulse Dynamics based in Marlton, NEW JERSEY (USA).
-
Quetiapine Impurity F (11-Chlorodibenzo[b,f][1,4]thiazepine)
An impurity of Quetiapine. Quetiapine is an atypical antipsychotic used for the treatment of schizophrenia.https://www.bocsci.com/quetiapine-impurity-f-11-chlorodibenzo-b-f-1-4-thiazepine-cas-13745-86-3-item-339591.html ...
By Alfa Chemistry based in NY, NEW YORK (USA).
-
N-Des[2-(2-hydroxyethoxy)ethyl] Quetiapine Dihydrochloride
A metabolite of Quetiapine. Quetiapine is an atypical antipsychotic used for the treatment of schizophrenia, bipolar disorder. https://www.bocsci.com/n-des-2-2-hydroxyethoxy-ethyl-quetiapine-dihydrochloride-cas-111974-74-4-item-54624.html ...
By Alfa Chemistry based in NY, NEW YORK (USA).
-
Healthy peripheral nervous system for nerve protection sector
Reliably locate nerves in altered anatomy or any time nerves are at ...
By Neuro Device Innovations (NDI) based in Cleveland, OHIO (USA).
-
Ultrasound for Anesthesiology
A single-probe ultrasound for whole-body assessment that plugs into your smart device, and fits in your pocket. Butterfly iQ+ is built for more control of regional nerve blocks, guided interventions and peri-operative ...
By Butterfly Network, Inc based in Guilford, CONNECTICUT (USA).
-
Thrive Hearing Control App
Do more with the Thrive Hearing Control app. The Thrive Hearing Control app gives the user full control over their hearing aids using their smartphone. Like a TV remote, it lets people adjust volume, switch memories and manage other features that hearing aids couldn’t do until ...
By Starkey Hearing Technologies based in Eden Prairie, MINNESOTA (USA).
-
Microscope System for Drug discovery and development
In this example, the aggregation of magnetic nanoparticles labeled with DiR is monitored in real time. Tumor microvasculature is labeled using ...
By Mauna Kea Technologies Office in Allston, MASSACHUSETTS (USA).
-
Artesunate Injection for Malaria Diagnosis of Malaria
The classical (but rarely observed) malaria attack lasts 6–10 ...
By Amivas (US), LLC based in Frederick, MARYLAND (USA).
-
Secca Therapy - Bowel Incontinence
An estimated 20 million people in the U.S. struggle with bowel incontinence, and an estimated 80% suffer in silence. Secca therapy is a safe, effective, minimally invasive procedure to treat bowel incontinence. Secca therapy is an innovative treatment option for patients with BCD, who have not responded to conservative treatments and would like to avoid invasive surgery or implants. ...
By Restech based in Houston, TEXAS (USA).
-
3D bioprinting technology for brain disease
Our RASTRUM matrices support a range of neural tissue cell types ranging from diseased to healthy cells (Glioblastoma, Neuroblastoma, Neurons, Astrocytes, Microglia, ...
By Inventia Life Science Pty Ltd (ILS) Office in Wilmington, DELAWARE (USA).
-
Solutions for Neuroscience
Our driving philosophy at Otsuka is to serve those with unmet medical needs, and that couldn’t be more true than in our dedication to the central nervous system (CNS) space. In our 30 years of experience working in this therapeutic area, we continue to innovate and defy limitation by taking risks to overcome the complexities of treating mental health. We respect the value within every mind and are committed to making a difference in the lives of patients living with schizophrenia, major depressive disorder, ...
By Otsuka America Pharmaceutical, Inc Office in Hayward, CALIFORNIA (USA).
-
Flagship Coil for Major Depressive Disorder (MDD) Treatment
A revolutionary depression treatment that has changed the field of mental healthcare, Deep TMS has been FDA-cleared to safely and effectively treat Major Depressive Disorder through BrainsWay’s patented H-coil ...
By BrainsWay Ltd. based in Burlington, MASSACHUSETTS (USA).
-
Flagship Coil for Smoking Addiction Treatment
BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS) is a safe and effective aid for short-term smoking cessation in adults, representing the first FDA clearance in the addiction space for any TMS ...
By BrainsWay Ltd. based in Burlington, MASSACHUSETTS (USA).
-
Flagship Coil for Alzheimer’s Disease Treatment
Alzheimer’s disease is a major cause of severe cognitive decline in the aged. The primary cognitive deficiencies are revealed in working memory, language, executive functions, attention, and long-term ...
By BrainsWay Ltd. based in Burlington, MASSACHUSETTS (USA).
-
Flagship Coil for Autism Disorder Treatment Technology
Autism is a complex developmental disability that typically appears during the first three years of life and is the result of a neurological disorder that affects the normal functioning of the brain. Autism is characterized by three kinds of symptoms: deficiency in social interaction, difficulties in verbal and non-verbal communication, and severe disabilities in interest areas and activities. In addition, autistic people may develop extreme reactions to noise, touch, or other sensory stimuli. These symptoms are ...
By BrainsWay Ltd. based in Burlington, MASSACHUSETTS (USA).
-
Natural Bionanomatrix Coating Technologies for Brain Aneurysm Industry
More than 3% of the population has unruptured cerebral aneurysms, approximately 10 million people in the US. About 30,000 rupture per year, with devastating consequences. More than 30% of patients with ruptured aneurysms die, and 4 of 7 who survive have significant disabilities. Detachable microcoils are now used in more than 70% of treated aneurysms. The risk of recurrence, or recanalization, remains surprisingly high at approximately 20-30%. Various modifications are used clinically with limited evidence that ...
By Endomimetics based in Birmingham, ALASKA (USA).
-
Sustained-Release Drug Delivery Platforms for Retinal Diseases
Glaukos is developing multiple micro-invasive, bioerodible, sustained-release drug delivery platforms designed to be used in the treatment of various retinal disease, including age-related macular degeneration (AMD) and diabetic macular ...
By Glaukos Corporation based in San Clemente, CALIFORNIA (USA).
-
Clinical Grade Parameters for Smartwatches
Medtor technology allows consumers for the first time to have clinically relevant heart rate and blood oxygenation data on the go and with normal activities. Benefits include improved workouts, enhanced fitness levels, and self-monitoring with potential early detection of health issues. ...
By Medtor Inc. based in Manhattan Beach, CALIFORNIA (USA).
-
Targeted genetic sequencing solutions for neurology sector
Over 50 million people globally are impacted by dementia. 25% of those over age 55 have a family history of dementia.* Tesis Labs Parkinson-Alzheimer-Dementia Panel examines 35 genes associated with an increased risk of developing neurodegenerative conditions: Parkinson’s disease, Alzheimer’s disease, Genetic disorders that cause ...
By Tesis Biosciences based in Scottsdale, ARIZONA (USA).
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you